Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Dec / Bacteriophage E. coli Test
Microbiology & Immunology Point of care testing Infectious Disease Microbiology and Immunology

Bacteriophage E. coli Test

New hydrogel biosensor enables rapid detection of bacteria in fluids

By Helen Bristow 12/02/2024 News 1 min read

Share

Researchers have developed a hydrogel biosensor combining DNAzyme technology, bacteriophages, and machine learning to detect Escherichia coli (E. coli) in environmental and clinical samples with high sensitivity and specificity. Their report, published in Advanced Materials, introduces a colorimetric detection platform capable of identifying E. coli at concentrations as low as 10 colony-forming units per milliliter (CFU/mL) within 18 hours.

The biosensor uses a hydrogel matrix embedded with gold nanoparticles (AuNPs) and crosslinked by E. coli-specific DNAzymes. Upon exposure to E. coli-secreted proteins, the DNAzyme cleaves, dissolving the hydrogel and releasing AuNPs, producing a visible color change. Bacteriophage T7, an E. coli-targeting virus, amplifies the detection signal by lysing bacterial cells to release more DNAzyme-activating proteins. This approach enhanced sensitivity by several orders of magnitude compared with traditional methods.

Credit: Georgia Kirkos, McMaster University

The platform demonstrated consistent results across real-world applications. In lake and cistern water samples, the biosensor reliably detected E. coli at levels of 10–100 CFU/mL. Testing with urine samples from patients with urinary tract infections (UTIs) achieved 100 percent accuracy, with no false positives in control samples. The biosensor maintained stability under various storage conditions, including long-term freezing, making it viable for field deployment and clinical use.

To eliminate subjective interpretation of the colorimetric results, researchers integrated an artificial intelligence (AI) model. The convolutional neural network achieved 96 percent true positive and 100 percent true negative rates in classifying contaminated and uncontaminated samples from optical images. This automation simplifies the biosensor's use in resource-limited settings.

Corresponding author Tohid Didar said, “Now we have a tool that can be used in food samples, environmental samples and clinical samples. Today, people who suspect they may have a UTI must visit a doctor and sometimes wait days for a result. This technology would make it very easy for people to test themselves at home and get a result in a matter of hours.”

The biosensor's ability to detect low bacterial loads rapidly and affordably positions it as a promising tool for water quality monitoring and at-home UTI diagnosis. Researchers plan to extend the platform’s capabilities by targeting additional pathogens, further enhancing its versatility for environmental and clinical diagnostics.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

What’s New in Infectious Disease? (December 2021)
Point of care testing
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Resisting Resistance
Point of care testing
Resisting Resistance

October 21, 2016

1 min read

Rapid, affordable tests to spot bacterial infections could reduce antibiotic overprescription in resource-limited settings

HIV/AIDS: A Shifting Epidemic
Point of care testing
HIV/AIDS: A Shifting Epidemic

April 4, 2022

1 min read

HIV diagnoses in heterosexual people in the UK have overtaken those in gay and bisexual men

Career Snapshots with Bamidele Farinre
Point of care testing
Career Snapshots with Bamidele Farinre

April 20, 2022

3 min read

Michael Schubert interviews Bamidele Farinre about her work in mobile laboratory testing

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.